INTRODUCTION
Due to the increase in high-energy trauma, complex fractures associated with extensive
skin lesions have become more frequent1. Places such as the distal extremity of the leg, ankle, heel and foot are a reconstructive
challenge. They are areas susceptible to trauma, plantar support, where chronic ulcers
and pressure can occur, besides having scarce subcutaneous tissue and bony prominences2.
An alternative for the treatment of these areas in the lower limbs is the use of the
sural flap, which was first described by Donski and Fogdestam (2015)6 Apud and later detailed by Masquelet et al. in 19924, who introduced the concept of a neurocutaneous island flap and described the sural
neurocutaneous flap, known as the sural retrograde flow flap2-4.
The sural flap has many advantages such as being easy and fast to perform, high survival
rates, fast learning curve1, preserves important arteries and muscles, in addition to great mobility, versatility
and flexibility, thus presenting a good rotation arc3,5.
It is not recommended to perform a flap in a large area (>9x12cm) for the distal third
of the leg due to the risk of poor perfusion and for regions where sensitivity would
be of great importance due to the sacrifice of the sural flap. Contraindication is
limited to the previous lesion of the vascular pedicle or the inferior perforating
of the sural artery6. But it is also associated with congestion due to poor venous drainage, skin necrosis,
unpleasant scars at the donor site and sensory disorders5,7. Such complications may be due to some risk factors such as age, diabetes mellitus,
obesity, peripheral vascular disease and smoking2,5.
OBJECTIVE
Perform a retrospective analysis of the results obtained in the surgical treatment
of lower limbs lesions using the sural flap.
METHODS
This was a retrospective, analytical-descriptive study of exploratory documental analysis,
approved by the institution’s research ethics committee, which was conducted under
number 29498220.3.0000.5362.
Medical records of patients submitted to surgical treatment using the sural flap were
evaluated to cover lower limbs lesions from January 2015 to March 2020.
The variables studied in this study were age, gender, laterality, cause, place, and
size of the lesion, use of tunneling and skin grafting, complications and their risk
factors, in addition to the management of such complications.
All procedures were performed by the same hand surgeon and microsurgery team 7-8, and the surgical technique used was based on the description of Masquelet et al.
(1992) 4, in which the patient in ventral or lateral decubitus was submitted to the anesthetic
procedure in addition to prophylactic antibiotic therapy for 24 hours (cefazolin).
The pivot point of the flap was marked approximately 5 cm above the lateral malleolus;
the surgical incision in the posterior part of the leg, between the muscle bellies
of the gastrocnemius muscles, from the skin to the sural fascia, where the vasculonervous
bundle is found. Dissection was performed from proximal to distal; the superficial
sural nerve and artery, in addition to the saphenous vein, were proximally connected,
so the flap that includes the fascia was elevated to the point of rotation.
A subcutaneous tunnel may transport the flap, or the pedicle may be externalized with
a skin syrup (having to undergo a second procedure for pedicle removal); flap rotation
and suture only of the skin with nylon 3.0 in the receiving area was performed. Soon
after, the perfusion of the flap was evaluated. If possible, the donor area is closed
primarily (island less than 4cm); if necessary, the partial-thickness skin graft of
the ipsilateral thigh is removed for coverage (Figures 1 and 2).
Figure 1 - A. Lesion in the lateral dorsum region of the left foot; B. Marking of surgical access;
C. Dissection and elevation of the sural flap.
Figure 1 - A. Lesion in the lateral dorsum region of the left foot; B. Marking of surgical access;
C. Dissection and elevation of the sural flap.
Figure 2 - A. Rotation and positioning of the flap under the lesion; B. Immediate postoperative;
C. Late postoperative period.
Figure 2 - A. Rotation and positioning of the flap under the lesion; B. Immediate postoperative;
C. Late postoperative period.
A sterile dressing was performed with gauze and orthopedic cotton, taking care not
to compress the flap; the drain was removed within 48 hours after the surgical procedure.
The flap was monitored 4 in 4 hours in the first 48 hours, and the patient was instructed
not to use foods that could cause vasoconstriction, such as chocolate and coffee.
Data inferential analysis was performed using the IBM Statistical Package for the
Social Sciences (SPSS) version 22.0 software.
Descriptive analysis was used to characterize the sample and lesion characteristics,
using ± standard deviation (SD) for quantitative variables and absolute number (n)
and percentage (%).
To compare the outcome: partial necrosis complication and the association with possible
predictor variables, Poisson regression was used to ascertain the relative risk (RR).
A p-value α =0.05 (p≤0.05) was adopted as the level for statistical significance.
RESULTS
The present study sample was composed of sixteen (n=16) patients who underwent surgical
treatment of lower limbs lesions using the sural flap (Table 1). The mean age was 44.4±17.7 years, and the highest prevalence was male 87.5% (n=14)
(Table 2).
Table 1 - Sample data (n=16).
No. |
Sex |
Age (years) |
Size (cm) |
Cause |
Local |
Risk factors |
Complications |
1 |
M |
57 |
8x6 |
Trauma |
Calcaneus |
SAH/Tab |
No |
2 |
M |
17 |
6X7 |
Trauma |
Distal tibia |
Tab |
No |
3 |
F |
57 |
6X5 |
Chronic ulcer |
Distal tibia |
SAH |
No |
4 |
M |
26 |
7X6 |
Trauma |
Calcaneus |
No |
No |
5 |
M |
38 |
7X7 |
Trauma |
Back of the foot |
No |
No |
6 |
M |
38 |
8x6 |
Trauma |
Distal tibia |
No |
Partial necrosis |
7 |
M |
67 |
7X3 |
Chronic ulcer |
Calcaneus |
SAH/Tab |
Partial necrosis |
8 |
M |
22 |
6X6 |
Trauma |
Distal tibia |
No |
No |
9 |
M |
74 |
7X4 |
Chronic ulcer |
Calcaneus |
SAH/PVD |
No |
10 |
M |
53 |
7X6 |
Trauma |
Calcaneus |
DM/Tab |
Partial necrosis |
11 |
M |
36 |
11x7 |
Trauma |
Back of the foot |
No |
No |
12 |
M |
56 |
12X6 |
Trauma |
Distal tibia |
No |
No |
13 |
M |
60 |
8x6 |
Trauma |
Distal tibia |
SAH |
Partial necrosis |
14 |
M |
20 |
14X7 |
Trauma |
Back of the foot |
No |
No |
15 |
F |
55 |
5x3 |
Trauma |
Distal tibia |
No |
No |
16 |
M |
34 |
15X10 |
Chronic ulcer |
Calcaneus |
Tab |
No |
Table 1 - Sample data (n=16).
Table 2 - Characterization of the sample (n=16).
Age (years) - mean ±SD |
44.4±17.7 |
Age (years) - median (IQR) |
60 (45-67) |
Gender - n (%) |
|
Male |
14 (87.5) |
Female |
2 (12.5) |
Table 2 - Characterization of the sample (n=16).
The cause of the most prevalent lesion was trauma 75.0% (n=12), and the site of the
lesion was more prevalent in the distal tibia 43.8% (n=7), with an average size of
52.9±33.4cm2. Tunneling of the pedicle was performed and grafting in 87.5% (n=14) of the lesions.
Regarding risk factors, 50.0% (n=8) had no risk factors. On the possible complications
during outpatient follow-up, partial necrosis had a prevalence of 25.0% (n=4). In
18.8% (n=3), only debridement was performed, and in 6.3% (n=1), partial skin grafting
at the complication sites (Table 3).
Table 3 - Characterization of the lesion (n=16).
Characteristics of the lesion |
n=16 |
Cause of injury - n (%) |
|
Trauma |
12 (75.0) |
Chronic ulcer |
4 (25.0) |
Site of injury - n (%) |
|
Distal tibia |
7 (43.8) |
Calcaneus |
6 (37.5) |
Back of the foot |
3 (18.8) |
Lesion size (cm 2) - mean ±SD |
52.9±33.4 |
Lesion size (cm2) - median (IIQ) |
45 (31.5-66.25) |
Pedicle tunneling - n (%) |
|
No |
14 (87.5) |
Yes |
2 (12.5) |
Grafting in the donor area - n (%) |
|
Yes |
14 (87.5) |
No |
2 (12.5) |
Risk factors - n (%) |
|
No |
8 (50.0) |
Smoking |
2 (12.5) |
SAH |
2 (12.5) |
SAH and smoking |
2 (12.5) |
SAH and PVD |
1 (6.3) |
DM and smoking |
1 (6.3) |
Complications - n (%) |
|
No |
12 (75.0) |
Partial necrosis |
4 (25.0) |
Management - n (%) |
|
Debridement |
3 (18.8) |
Grafting |
1 (6.3) |
Unspecified |
12 (75.0) |
Table 3 - Characterization of the lesion (n=16).
The prevalence of partial necrosis outcome was 25.0% in the sample studied. It is
observed in the univariate analysis between the outcome and the predictor variables,
which have as risk factors before surgery, diabetes mellitus and being a smoker, is
a risk factor 5 times greater of having as partial complication necrosis of the flap
(RR: 5.00; CI 95%:1.82-13.76; p≤0.05) (Table 4).
Table 4 - Factors associated with outcome complications: partial necrosis.
|
n (%) |
Gross RR |
CI 95% |
p |
Sample characterization |
|
|
|
|
Age - ≥55 years |
8 (50.0) |
3.00 |
0.39-23.1 |
0.29 |
Gender - Male |
14 (87.5)) |
- |
- |
- |
Characterization of the lesion |
|
|
|
|
Cause - Trauma |
12 (75.0) |
1.00 |
0.14-7.10 |
1.00 |
Location - Calcaneus |
6 (37.5) |
1.67 |
0.33-8.93 |
0.55 |
Location - Distal Tibia |
7 (43.8) |
1.29 |
0.24-6.99 |
0.77 |
Location - Back of the foot |
3 (18.8) |
- |
- |
- |
Tunneling |
2 (12.5) |
2.33 |
0.42-12.9 |
0.33 |
Risk factors - Yes |
8 (50.0) |
3.00 |
0.39-23.07 |
0.29 |
Risk factors - SAH |
2 (12.5) |
2.33 |
0.42-12.9 |
0.33 |
Risk Factors - Smoking |
2 (12.5) |
- |
- |
- |
Risk factors - SAH and smoking |
2 (12.5) |
2.33 |
0.42-12.9 |
0.33 |
Risk factors - DM and smoking |
1 (6.3) |
5.00 |
1.82-13.76 |
0.01* |
Risk factors - SAH and PVD |
1 (6.3) |
- |
- |
- |
Management - Debridement |
3 (75.0) |
- |
- |
- |
Management - Grafting |
1 (25.0) |
- |
- |
- |
Table 4 - Factors associated with outcome complications: partial necrosis.
DISCUSSION
Based on the results obtained, the complications of the sural flap can be correlated
concerning risk factors, besides evaluating the variation of the determinants of the
evolution of the disease related to treatment.
In other studies, similar data were found in ours, in which young patients with a
mean age of 44 years and males were the most prevalent, probably due to the cause
of the injury being the vast majority due to trauma1,2,5,9.
It was observed the similarity of results, in other studies, that the distal third
of the leg and calcaneus were the most prevalent sites of the lesions. This study
also observed these results, being present in 7 cases in the distal third of the leg,
followed by the calcaneus with 6 cases2,10.
According to Quirino and Viegas (2014)11, there was a need for partial skin grafting in the donor area in 11 of the 12 patients
in their study, a result like ours, performed in 14 patients. We chose to tunnel in
only 2 cases in our work, while Quirino and Viegas (2014)11 performed in 5 cases. For Vendramin (2012)10, the choice may vary according to the location and the presence of complications
already observed in the intraoperative period, such as vascular compression of the
pedicle; we used the same criteria for the decision of tunneling. In our study, it
did not influence the final result of the flap, a fact also found in the work of Parrett
et al. (2009)12.
We considered a good final result in the treatment using the sural flap because, in
only 25%, there was partial necrosis and in no case the total necrosis of the flap
(Figure 3). Such data are similar to those found in other studies such as that of Singh et
al. (2017) 1, in which there was partial necrosis in 2 of the 15 patients studied. In contrast,
Ciofu et al. (2017) 13 reported a complication rate of 30% in a population of high-risk patients, including
patients with diabetes mellitus, peripheral vascular disease, and venous insufficiency.
Vendramin (2012)10 obtained partial necrosis in 18.5% and total necrosis in 3.7% in the first phase
of his work, in which the author had performed the surgeries with less experience
with the technique. These results improved in the second phase, with more experience.
There was partial necrosis in only 8.8% of the cases, being the surgeon’s experience
a factor that can interfere in the outcome of the surgery and better results in future
cases.
Figure 3 - A. lesion in the region of the right heel (patient number 10); B. Immediate postoperative
of the sural flap; C. Late postoperative period presenting partial necrosis of the
flap.
Figure 3 - A. lesion in the region of the right heel (patient number 10); B. Immediate postoperative
of the sural flap; C. Late postoperative period presenting partial necrosis of the
flap.
Diabetes mellitus, hypertension, smoking and peripheral vascular disease are risk
factors for postoperative complications, and they were present in 50% (8 cases) of
the patients in the study. That is a number greater than that found in the work of
Severo et al. (2019) 5, in which risk factors were observed in 3 of the 24 medical records and in Garcia’s
(2009)2 that was found in 6 of the 15 patients. Therefore, this may be a determining factor
for lower rates of partial necrosis such as those of Severo et al. (2019) 5 with 8.3% and Garcia (2009)2 with only one case reported. This fact was proven with the study by Parrett et al.
(2009) 12, who, comparing only the group of patients with diabetes, peripheral vascular disease
and smoking, had complications in 78% of the cases, different from the group without
comorbidities, with 16%.
When compared with other risk factors, this becomes even more evident, as demonstrated
by Baumeister et al. (2003) 14 who presented complications in 11% of healthy patients, 33% in patients with coexisting
diseases, such as hypertonia, obesity, coronary artery disease or paraplegia, and
60% in diabetics, with venous insufficiency and peripheral arterial disease probably
caused by macro and microangiopathy caused by these diseases. Furthermore, in the
same study, it was proven that patients with any of these comorbidities have a 5 to
6 times greater chance of flap necrosis.
In a systematic review that evaluated risk factors concerning pediculate flaps used
in the lower limbs, it was observed that there was no significant increase in relative
risk in smokers. However, smoking almost reached statistical significance as a risk
factor3. In our study, smokers and diabetic patients were five times more likely to have
partial necrosis of the flap.
Despite the occurrence of complications, most of the time, we conducted only with
debridement, sterile dressing without adding medications and observation of the wound
until its healing by second intention, which occurred within four weeks, and skin
grafting is necessary in only one case. Similar conduct was also taken by other authors,
who in all their cases treated partial necrosis conservatively3,5,10,15.
CONCLUSION
According to the results demonstrated here and in the literature, we can conclude
that the sural flap is a good alternative for the coverage of lower limb lesions due
to the good success rate with few complications. However, despite the advantages,
this type of flap is not free of complications, but most of the times, they cause
little morbidity and are easy to manage.
We should be aware of the risk factors of these complications such as diabetes, peripheral
vascular disease, hypertension, and smoking; and, especially, when there is an association
of factors in the same patient, such as diabetes and smoking, which increased the
risk of partial necrosis of the flap by five times.
COLLABORATIONS
PSB
|
Analysis and/or data interpretation, Conception and design study, Data Curation, Final
manuscript approval, Project Administration, Writing - Original Draft Preparation
|
HA
|
Final manuscript approval
|
TSS
|
Conception and design study, Final manuscript approval, Project Administration
|
TSB
|
Analysis and/or data interpretation, Conception and design study, Formal Analysis,
Methodology
|
REFERENCES
1. Singh KK, Rohilla R, Singh R, Singh S, Singh B, Tanwar M. Outcome of distally based
sural artery flap for distal third of leg and foot defects. J Ayub Med Coll Abbottabad.
2017 Jul/Set;29(3):462-5.
2. Garcia AMC. Retalho sural reverso para reconstrução distal da perna, tornozelo, calcanhar
e do pé. Rev Bras Cir Plást. 2009;24(1):96-103.
3. Dalponte M. Retalho sural para reconstrução do pé. Arq Catarin Med. 2007 Jun;36(Supl
1):1-4.
4. Masquelet AC, Romana MC, Wolf G. Skin island flaps supplied by the vascular axis of
the sensitive superficial nerves: anatomic study and clinical experience in the leg.
Plast Reconstr Surg. 1992 Jun;89(6):1115-21.
5. Severo AL, Coppi EFM, Cavalheiro HL, Dal Bosco AL, Barreto Filho D, Lemos MB. Reconstrução
de membro inferior-retalho fasciocutâneo sural. Rev Bras Ortop. 2019 Mar/Abr;54(2):128-33.
6. Sauerbier M. Retalho sural. In: Moran LS, Cooney PW, eds. Cirurgia de tecidos moles:
master techniques in orthopedic. São Paulo: Thieme Revinter; 2015.
7. Grandjean A, Romana C, Fitoussi F. Retalho sural de base distal para cobertura de
tornozelo e pé em crianças. Ortop Traumatol Cirur Pesq. 2016;102(1):111-6.
8. D'Avila F, Franco D, D'Avila B, Arnaut Junior M. Use of local muscle flaps to cover
leg bone exposures. Rev Col Bras Cir. 2014 Nov/Dez;41(6):434-9.
9. Dhamangaonkar AC, Patankar HS. Reverse sural fasciocutaneous flap with a cutaneous
pedicle to cover distal lower limb soft tissue defects: experience of 109 clinical
cases. J Orthop Traumatol. 2014 Set;15(3):225-9.
10. Vendramin FS. Retalho sural de fluxo reverso: 10 anos de experiência clínica e modificações.
Rev Bras Cir Plást. 2012;27(2):309-15.
11. Quirino AC, Viegas KC. Retalhos fasciocutâneos para cobertura de lesões no pé e tornozelo.
Rev Bras Ortop. 2014;49(2):183-8.
12. Parrett BM, Pribaz JJ, Matros E, Przylecki W, Sampson CE, Orgill DP. Risk analysis
for the reverse sural fasciocutaneous flap in distal leg reconstruction. Plast Reconstr
Surg. 2009 Mai;123(5):1499-504.
13. Ciofu RN, Zamfirescu DG, Popescu AS, Lascar I. Reverse sural flap for ankle and heel
soft tissues reconstruction. J Med Life. 2017 Jna/Mar;10(1):94-8.
14. Baumeister SP, Spierer R, Erdmann D, Sweis R, Levin LS, Germann GK. A realistic complication
analysis of 70 sural artery flaps in a multimorbid patient group. Plast Reconstr Surg.
2003 Jul;112(1):129-40;discussion:141-2.
15. Chang SM, Li XH, Gu YD. Distally based perforator sural flaps for foot and ankle reconstruction.
World J Orthop. 2015 abr;6(3):322-30. Figura 2. A. Rotação e posicionamento do retalho
sob a lesão; B. Pós-operatório imediato; C. Pós-operatório tardio.
1. Hospital Municipal São José, Joinville, SC, Brazil.
2. Joinville Institute of Orthopedics and Traumatology, Joinville, SC, Brazil.
3. Institute of Higher Education of Vale do Parnaíba, Parnaíba, PI, Brazil.
*Corresponding author:
Pedro Simão Bosse, Rua Santo Antônio, nº 414, apto 601, Centro, Criciúma, SC, Brazil, Zip Code 88801-440.
E-mail: pedrobosse@hotmail.com
Article received: December 14, 2020.
Article accepted: April 23, 2021.
Conflicts of interest: none.